Changeflow GovPing Healthcare & Life Sciences 12-Week In-Phase Bilateral Exercise Programme I...
Routine Notice Added Final

12-Week In-Phase Bilateral Exercise Programme Improves Corticospinal Plasticity in Progressive Multiple Sclerosis

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

Five individuals with Progressive Multiple Sclerosis completed a 12-week exercise programme of in-phase bilateral upper-limb movements three times per week, with brain activity measured via transcranial magnetic stimulation (TMS). The single-case experimental design with repeated baseline and intervention measurements assessed corticospinal excitability and functional outcomes including walking speed, balance, and cognition. Results are posted on ClinicalTrials.gov as a completed registry entry.

“In this study, five individuals with Progressive Multiple Sclerosis participated in a 12-week exercise program consisting of in-phase bilateral upper-limb movements performed three times per week.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

NCT07548242 is a registered clinical trial entry on ClinicalTrials.gov describing a prospective single-site exploratory study. The study enrolled five participants with Progressive Multiple Sclerosis to evaluate whether a structured 12-week in-phase bilateral upper-limb exercise programme (three sessions per week) can produce measurable neurophysiological and functional changes, assessed via TMS active motor threshold measurements and clinical outcome measures.

The registry entry is informational and does not impose regulatory obligations on any party. Healthcare researchers conducting similar neurological rehabilitation studies should be aware that the study was prospectively registered on ClinicalTrials.gov; results posting is a transparency requirement rather than a compliance obligation. Peer institutions or sponsors reviewing this entry for protocol design purposes may note the TMS measurement methodology and single-case experimental design as potential reference points.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Effects of a 12-week In-phase Bilateral Exercise Programme on the Corticospinal Plasticity in People With Progressive Multiple Sclerosis

N/A NCT07548242 Kind: NA Apr 23, 2026

Abstract

This study investigates whether a structured exercise program using coordinated movements of both arms can improve brain and motor function in people with Progressive Multiple Sclerosis (MS). Progressive MS is associated with gradual worsening of neurological function, including difficulties with movement, strength, balance, and cognition. Because current medications have limited effects on disease progression, rehabilitation strategies that promote brain plasticity and functional recovery are increasingly important.

In this study, five individuals with Progressive Multiple Sclerosis participated in a 12-week exercise program consisting of in-phase bilateral upper-limb movements performed three times per week. Brain activity related to movement was measured using transcranial magnetic stimulation (TMS), which assessed corticospinal excitability through active motor threshold measurements. Additional clinical tests evaluated walking speed, balance, hand dexterity, muscle strength, cognitive processing speed, fatigue, and quality of life. The study used a single-case experimental design with repeated measurements during baseline and intervention phases to determine whether the exercise program produced measurable neurophysiological and functional changes.

Conditions: Progressive Multiple Sclerosis (PMS)

Interventions: In-Phase Bilateral Upper Limb Exercise Program

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
NCT07548242

Who this affects

Applies to
Healthcare providers Clinical investigators Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Neurophysiological research MS rehabilitation study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!